Journal of Cancer Therapy
Vol.10 No.10(2019), Paper ID 95546, 9
pages
DOI:10.4236/jct.2019.1010068
Impact of MGMT Promoter Methylation as a Prognostic Marker in Patients with High Grade Glioma: A Single-Center Observational Study
Vinu Sarathy, Srinivasa Belagutty Jayappa, Bhanu Lalkota, Kiran Pura Krishnamurthy, Vishal Kulkarni, Samuel Luke Koramati, Nasiruddin Mohammad, Radheshyam Naik
Department of Medical Oncology, Health Care Global Enterprises Ltd., Bangalore, India
Department of Medical Oncology, Health Care Global Enterprises Ltd., Bangalore, India
Department of Medical Oncology, Health Care Global Enterprises Ltd., Bangalore, India
Department of Medical Oncology, Health Care Global Enterprises Ltd., Bangalore, India
Department of Medical Oncology, Health Care Global Enterprises Ltd., Bangalore, India
Department of Medical Oncology, Health Care Global Enterprises Ltd., Bangalore, India
Department of Medical Oncology, Health Care Global Enterprises Ltd., Bangalore, India
Department of Medical Oncology, Health Care Global Enterprises Ltd., Bangalore, India
Copyright © 2019 Vinu Sarathy, Srinivasa Belagutty Jayappa, Bhanu Lalkota, Kiran Pura Krishnamurthy, Vishal Kulkarni, Samuel Luke Koramati, Nasiruddin Mohammad, Radheshyam Naik et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Sarathy, V. , Jayappa, S. , Lalkota, B. , Krishnamurthy, K. , Kulkarni, V. , Koramati, S. , Mohammad, N. and Naik, R. (2019) Impact of MGMT Promoter Methylation as a Prognostic Marker in Patients with High Grade Glioma: A Single-Center Observational Study.
Journal of Cancer Therapy,
10, 806-814. doi:
10.4236/jct.2019.1010068.